Published in J Clin Invest on September 01, 1983
Canine malignant hyperthermia susceptibility: erythrocytic defects--osmotic fragility, glucose-6-phosphate dehydrogenase deficiency and abnormal Ca2+ homeostasis. Can J Comp Med (1984) 1.68
Abnormal ryanodine receptor channels in malignant hyperthermia. Biophys J (1990) 1.65
Caffeine induces Ca2+ release by reducing the threshold for luminal Ca2+ activation of the ryanodine receptor. Biochem J (2008) 1.33
Ryanodine receptor channelopathies. Pflugers Arch (2010) 1.33
The human ryanodine receptor gene: its mapping to 19q13.1, placement in a chromosome 19 linkage group, and exclusion as the gene causing myotonic dystrophy. Am J Hum Genet (1990) 1.31
Porcine malignant hyperthermia susceptibility: hypersensitive calcium-release mechanism of skeletal muscle sarcoplasmic reticulum. Can J Vet Res (1986) 1.10
Abnormal human sarcoplasmic reticulum Ca2+ release channels in malignant hyperthermic skeletal muscle. Biophys J (1991) 0.97
Skeletal and cardiac ryanodine receptors exhibit different responses to Ca2+ overload and luminal ca2+. Biophys J (2007) 0.96
Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia. FASEB J (2012) 0.92
The genetics of malignant hyperthermia. J Med Genet (1993) 0.89
Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers. BMJ (1991) 0.88
Reduced threshold for luminal Ca2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia. J Biol Chem (2008) 0.88
Malignant hyperthermia susceptibility: biochemical basis for pathogenesis and diagnosis. Can J Vet Res (1990) 0.88
Detection of a novel mutation in the ryanodine receptor gene in an Irish malignant hyperthermia pedigree: correlation of the IVCT response with the affected and unaffected haplotypes. J Med Genet (1997) 0.84
Genome-wide detection and characterization of positive selection in Korean Native Black Pig from Jeju Island. BMC Genet (2015) 0.76
Strenuous exercise triggers a life-threatening response in mice susceptible to malignant hyperthermia. FASEB J (2017) 0.75
[Malignant hyperthermia]. Wien Klin Wochenschr (2003) 0.75
Calcium release from the sarcoplasmic reticulum. Physiol Rev (1977) 10.59
Malignant hyperthermia: a statistical review. Can Anaesth Soc J (1970) 4.51
Metabolic error of muscle metabolism after recovery from malignant hyperthermia. Lancet (1970) 3.32
Anaesthetic deaths in a family. Br J Anaesth (1962) 2.50
Malignant hyperthermia. Anesthesiology (1980) 2.47
Studies on the mechanism of action of dantrolene sodium. A skeletal muscle relaxant. Naunyn Schmiedebergs Arch Pharmacol (1972) 2.02
Biochemical basis of malignant hyperpyrexia. Br Med J (1974) 2.01
Anaesthetic-induced malignant hyperpyrexia and a method for its prediction. Br J Anaesth (1969) 1.83
Inhibition of the intracellular release of calcium by Dantrolene in barnacle giant muscle fibres. J Physiol (1977) 1.73
Mechanism of calcium release from skeletal sarcoplasmic reticulum. J Membr Biol (1982) 1.56
Effect of dantrolene sodium on calcium movements in single muscle fibres. Nature (1974) 1.49
The mechanism of action of dantrolene sodium. J Pharmacol Exp Ther (1977) 1.47
Dantrolene in human malignant hyperthermia. Anesthesiology (1982) 1.36
The caffeine test of isolated human muscle in relation to malignant hyperthermia. Can Anaesth Soc J (1977) 1.09
Calcium-induced calcium release from fragmented sarcoplasmic reticulum. J Biochem (1979) 1.08
Malignant hyperthermia of Poland China swine: studies of a myogenic etiology. Anesthesiology (1972) 1.01
Calcium-induced calcium release at terminal cisternae of skeletal sarcoplasmic reticulum. FEBS Lett (1981) 0.98
Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle. Anesthesiology (1975) 0.97
Characteristics of sarcoplasmic reticulum from slowly glycolysing and from rapidly glycolysing pig skeletal muscle post mortem. Biochem J (1977) 0.95
Malignant hyperthermia of swine. Anesthesiology (1972) 0.94
Skeletal muscle sarcoplasmic reticulum in porcine malignant hyperthermia. Eur J Pharmacol (1979) 0.89
Influence of fluothane on calcium accumulation by the heavy microsomal fraction of human skeletal muscle: comparison with a patient with malignant hyperpyrexia. Biochem Med (1972) 0.85
The adenosine triphosphate (ATP) depletion test: comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility. Can Anaesth Soc J (1976) 0.84
Porcine malignant hyperthermia: observations on the occurrence of pale, soft, exudative musculature among susceptible pigs. Am J Vet Res (1974) 0.84
Metabolism of striated muscle of stress-susceptible pigs breathing oxygen or nitrogen. Am J Physiol (1970) 0.83
Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis. Anesthesiology (1980) 0.82
Calcium content and contracture in isolated muscle of malignant hyperthermia in pigs. J Pharmacol Exp Ther (1981) 0.82
The trigger for PSE condition in stress-susceptible pigs. J Sci Food Agric (1976) 0.81
Malignant hyperthermia: diagnosis, treatment and investigations of a skeletal muscle lesion. Tex Rep Biol Med (1979) 0.81
Calcium movements in skeletal muscle mitochondria of malignant hyperthermic pigs. FEBS Lett (1978) 0.81
Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermia. Anesthesiology (1979) 0.79
Calcium transport and release by sarcoplasmic reticulum: a mini-review. Soc Gen Physiol Ser (1979) 0.78
Temperature perturbation studies of sarcoplasmic reticulum from malignant hyperthermia pig muscle. J Clin Invest (1979) 0.77
A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology (1994) 3.23
Purification of an exo-beta-D-(1 bonded to 3)-glucanase from Basidiomycete species QM 806. J Biol Chem (1968) 2.30
Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol (1997) 1.65
Current concepts. The malignant hyperthermia syndrome. N Engl J Med (1983) 1.43
Studies on the action of amylo-I,6-glucosidase. Biochim Biophys Acta (1970) 1.39
Ability of different physical activity monitors to detect movement during treadmill walking. Int J Sports Med (2003) 1.39
Separation and characterization of the soluble and insoluble components of insoluble laminaran. Carbohydr Res (1974) 1.31
Protein kinase C-mediated enhancement of NMDA currents by metabotropic glutamate receptors in Xenopus oocytes. J Physiol (1992) 1.20
Action pattern and specificity of an exo-beta-(1--3)-D-glucanase from basidiomycetes species QM 806. J Biol Chem (1969) 1.18
Malignant hyperthermia and apparent heat stroke. JAMA (2001) 1.16
Dantrolene dose response in awake man: implications for management of malignant hyperthermia. Anesthesiology (1983) 1.15
Association of gylcogenolysis with cardiac sarcoplasmic reticulum. J Biol Chem (1976) 1.02
Single-amino-acid deletion in the RYR1 gene, associated with malignant hyperthermia susceptibility and unusual contraction phenotype. Am J Hum Genet (2001) 1.02
Malignant hyperthermia of Poland China swine: studies of a myogenic etiology. Anesthesiology (1972) 1.01
The transient depression of hippocampal CA1 LTP induced by chronic intermittent ethanol exposure is associated with an inhibition of the MAP kinase pathway. Eur J Neurosci (2003) 1.00
[3H]ryanodine as a probe of changes in the functional state of the Ca(2+)-release channel in malignant hyperthermia. J Biol Chem (1992) 1.00
Evaluation of suspected osteoid osteoma. Clin Orthop Relat Res (1996) 0.99
Purification and properties of rabbit muscle amylo-1,6-glucosidase-oligo-1,4-1,4-transferase. Biochemistry (1969) 0.98
Long-term potentiation in the rat hippocampus is reversibly depressed by chronic intermittent ethanol exposure. J Neurophysiol (2002) 0.98
Carnosine is a novel peptide modulator of intracellular calcium and contractility in cardiac cells. Am J Physiol (1997) 0.97
Abnormal human sarcoplasmic reticulum Ca2+ release channels in malignant hyperthermic skeletal muscle. Biophys J (1991) 0.97
Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle. Anesthesiology (1975) 0.97
The hydrolytic mechanism of an exo-beta-(1--3)-D-glucanase. J Biol Chem (1970) 0.97
Malignant hyperthermia of swine. Anesthesiology (1972) 0.94
Identification and functional characterization of a novel ryanodine receptor mutation causing malignant hyperthermia in North American and South American families. Neuromuscul Disord (2001) 0.93
Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Anesthesiology (2001) 0.89
Neurobehavioral effects of neonatal hypermagnesemia. J Pediatr (1982) 0.89
Re-evaluation of the subunit structure and molecular weight of rabbit muscle amylo-1,6-glucosidase-4-alpha-glucanotransferase. Biochim Biophys Acta (1974) 0.89
Amylo-1,6-glucosidase/4-alpha-glucanotransferase: use of reversible substrate model inhibitors to study the binding and active sites of rabbit muscle debranching enzyme. Biochemistry (1977) 0.89
The action of the glycogen debranching enzyme system in a muscle protein particle. Biochem Biophys Res Commun (1972) 0.89
Porcine malignant hyperthermia: a study on the triggering effects of succinylcholine. Anesth Analg (1974) 0.88
Is comparative cardiotoxicity of S(-) and R(+) bupivacaine related to enantiomer-selective inhibition of L-type Ca(2+) channels? Anesth Analg (2001) 0.87
Studies on normal human skeletal muscle in relation to the pathopharmacology of malignant hyperpyrexia. Clin Exp Pharmacol Physiol (1977) 0.87
North American malignant hyperthermia population: screening of the ryanodine receptor gene and identification of novel mutations. Anesthesiology (2001) 0.86
Annexin VI is associated with calcium-sequestering organelles. J Cell Biochem (1991) 0.84
Porcine malignant hyperthermia: observations on the occurrence of pale, soft, exudative musculature among susceptible pigs. Am J Vet Res (1974) 0.84
The attack mechanism of an exo-1,3-beta-glucosidase from Basidiomycete sp. QM 806. Biochim Biophys Acta (1975) 0.84
Somatic Ca2+ signaling in cerebellar Purkinje neurons. J Neurosci Res (2010) 0.83
Spectrum of susceptibility to malignant hyperthermia--diagnostic dilemma. Anesth Analg (1983) 0.83
Thyroxine modulation of epinephrine stimulated secretion of rat parotid -amylase. Biochem Biophys Res Commun (1972) 0.82
Calcium content and contracture in isolated muscle of malignant hyperthermia in pigs. J Pharmacol Exp Ther (1981) 0.82
A rapid micro assay method for amylo-1,6-glucosidase. Anal Biochem (1970) 0.82
Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis. Anesthesiology (1980) 0.82
Massive postoperative rhabdomyolysis after uneventful surgery: a case report of subclinical malignant hyperthermia. Anesthesiology (1998) 0.81
Malignant hyperthermia: diagnosis, treatment and investigations of a skeletal muscle lesion. Tex Rep Biol Med (1979) 0.81
Porcine malignant hyperthermia. Am J Pathol (1976) 0.81
Screening for malignant hyperpyrexia. Br J Anaesth (1977) 0.81
Ryanodine: antithetical calcium channel effects in skeletal muscle sarcoplasmic reticulum. J Pharmacol Exp Ther (1987) 0.80
The use of MRI in the diagnosis of benign and malignant bone and soft tissue tumours. Australas Radiol (1993) 0.80
Malignant melanoma: Mayo Clinic experience. Mayo Clin Proc (1997) 0.80
Comparison of Ca++ uptake and spontaneous Ca++ release from sarcoplasmic reticulum vesicles isolated from muscle of malignant hyperthermia diagnostic patients. J Pharmacol Exp Ther (1987) 0.80
The rate of wound healing is increased in psoriasis. J Dermatol Sci (2013) 0.80
Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermia. Anesthesiology (1979) 0.79
Is theophylline, aminophylline, or caffeine (methylxanthines) contraindicated in malignant hyperthermia susceptible patients? Anesth Analg (1983) 0.79
Reinvestigation of the pH optimum in terms of the action and properties of rabbit muscle amylo-1,6-glucosidase-oligo-1,4 to 1,4-transferase. Biochim Biophys Acta (1968) 0.79
Thiol/disulfide redox equilibrium between glutathione and glycogen debranching enzyme (amylo-1,6-glucosidase/4-alpha-glucanotransferase) from rabbit muscle. J Biol Chem (1986) 0.79
Purification of glycogen debranching enzyme from rabbit muscle using omega-aminoalkyl agarose chromatography. Anal Biochem (1981) 0.79
Halothane-succinylcholine induced masseter spasm: indicative of malignant hyperthermia susceptibility? Anesth Analg (1984) 0.78
Estrogen and prothrombin synthesis: effect of estrogen on absorption of vitamin K1. Am J Physiol (1977) 0.78
Central core disease and malignant hyperthermia syndrome. Ann Neurol (1980) 0.78
Carnosine: a novel peptide regulator of intracellular calcium and contractility in cardiac muscle. New Horiz (1996) 0.78
Temperature perturbation studies of sarcoplasmic reticulum from malignant hyperthermia pig muscle. J Clin Invest (1979) 0.77
Porcine malignant hyperthermia--failure of dantrolene dose response to diagnose susceptibility (halothane effect). Can Anaesth Soc J (1980) 0.77
Malignant hyperthermia--diagnostic dilemma: false-negative contracture responses with halothane and caffeine alone. Anesth Analg (1994) 0.77
Urea toxicity studies in the bovine. J Anim Sci (1969) 0.77
Malignant hyperthermia: is etomidate safe? Anesth Analg (1985) 0.77
Malignant hyperthermia: a disease of specific myofiber type? Can Anaesth Soc J (1982) 0.76
Dantrolene does not block calcium pulse-induced calcium release from a putative calcium channel in sarcoplasmic reticulum from malignant hyperthermia and normal pig muscle. FEBS Lett (1984) 0.76
Analytical gel chromatography of rabbit muscle amylo-1,6-glucosidase/4-alpha-glucanotransferase under denaturing and non-denaturing conditions. Biochim Biophys Acta (1975) 0.75
Combined caffeine-halothane test for malignant hyperthermia. Br J Anaesth (1993) 0.75
Diagnosing malignant hyperthermia. Plast Reconstr Surg (1989) 0.75
Prophylactic and therapeutic doses of dantrolene for malignant hyperthermia. Anesthesiology (1984) 0.75
Induction of ovulation. J Kans Med Soc (1969) 0.75
Effect of dantrolene on neouromuscular block by d-tubocurarine and subsequent antagonism by neostigmine in the rabbit. Anesthesiology (1980) 0.75
Prolonged electromechanical coupling time intervals in skeletal muscle of pigs susceptible to malignant hyperthermia. Muscle Nerve (1983) 0.75
Calcium status studies on adult sheep. J Nutr (1967) 0.75
The Albrecht nursing model for home healthcare: predictors of health status outcomes in working adults. J Nurs Adm (1993) 0.75
Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle. J Pharmacol Exp Ther (1997) 0.75
Suxamethonium and MHS muscle. Br J Anaesth (1988) 0.75
Improved purification procedure for rabbit muscle amylo-1,6-glucosidase-oligo-1,4 leads to 1,4-glucantransferase. Anal Biochem (1972) 0.75
Pregnancy: increased effect of verapamil in human uterine arteries. Eur J Pharmacol (1985) 0.75
Malignant hyperthermia. Anesth Analg (1980) 0.75
Treatment of malignant hyperthermia in swine. Anesth Analg (1973) 0.75
Does prior dantrolene affect the in vitro diagnosis of malignant hyperthermia susceptibility? Can Anaesth Soc J (1979) 0.75
Malignant hyperthermia: skeletal muscle defect(s) predisposing to labile Ca2+ regulation? J Child Neurol (1992) 0.75
Disc electrophoresis: an improved technique. J Lab Clin Med (1966) 0.75
Amylo-1,6-glucosidase/4-alpha-glucanotransferase. Reaction of rabbit muscle debranching enzyme with an active site-directed irreversible inhibitor, 1-S-dimethylarsino-1-thio-beta-D-glucopyranoside. J Biol Chem (1980) 0.75
Biphasic adrenergic responses of rabbit aorta. Microvasc Res (1974) 0.75
Masseter spasm induced by succinylcholine in children: contracture testing for malignant hyperthermia: report of six cases. Can Anaesth Soc J (1982) 0.75
Cystic fibrosis: isolation and physical properties of a salivary cystic fibrosis factor. Pediatr Res (1978) 0.75
In vivo and in vitro responses to magnesium sulphate in porcine malignant hyperthermia. Can Anaesth Soc J (1980) 0.75
Creatine supplementation and swimming performance. Int J Sport Nutr (1999) 0.75
Influence of age and calcium-free diet on thyroparathyroidectomized sheep. J Nutr (1969) 0.75
An investigation of the properties of rabbit muscle oligo-1,4--1,4-glucantransferase. Biochim Biophys Acta (1970) 0.75
Lack of relationship between hypoprothrombinemia and transvascular protein exchange. Am J Physiol (1966) 0.75
Estrogen and prothrombin synthesis. The prothrombinogenic action of estrogen. Biochem Biophys Res Commun (1977) 0.75
Multiple channel gel immunoelectrophoresis: a further step towards standardization. J Med Lab Technol (1969) 0.75
Specificity of an isolated salivary factor material to cystic fibrosis. Pediatr Res (1981) 0.75
Cystic fibrosis: enzymatic detection of a ciliostatic factor. Pediatr Res (1976) 0.75
Calcium and magnesium content of skeletal muscle. Studies in subjects undergoing diagnostic testing for malignant hyperthermia. Br J Anaesth (1987) 0.75